| Ytd | 87.75% | |
| 1y | 18.78% |
| Open | 1.08 | Prev Close | 1.08 | Low | 1.07 | High | 1.09 | Mkt Cap | 13.83M |
| Vol | 10.12K | Avg Vol | 270.15K | EPS | -1.07 | P/E | -1.01 | Forward P/E | -1.17 |
| Beta | 0.81 | Short Ratio | 0.08 | Inst. Own | 20.68% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 0.98 | 200-d Avg | 0.93 | 1yr Est | 11.50 |
Biofrontera Inc. (BFRI) Shareholder/Analyst Call Prepared Remarks Transcript
WOBURN, Mass. , May 21, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) ("Biofrontera" or t
Top Wall Street analysts upgraded STUB, PGNY, AMT, and BAP stocks and raised their price targets. Se
Biofrontera Inc. (BFRI) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus
Woburn, MA, May 14, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ: BFRI) (the "Company"), a biop
The second annual #HatsonforAK Campaign runs May 18–24, 2026, culminating on Global Actinic Keratosi
WOBURN, Mass. , May 08, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) ("Biofrontera" or t
Biofrontera (NASDAQ: BFRI) reported record revenue for both the fourth quarter and full year 2025, d
Biofrontera Inc. (BFRI) Q4 2025 Earnings Call Transcript
Conference call will be held today, Thursday, March 19 at 10:00 am ET Woburn, MA, March 19, 2026 (GL
WOBURN, Mass., March 09, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or
Biofrontera Inc. (BFRI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism abou
• Phase 2b study demonstrated greater reductions in inflammatory acne lesions with Ameluz ® PDT vers
WOBURN, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutica
RenovaCare (OTCMKTS:RCAR - Get Free Report) and Biofrontera (NASDAQ: BFRI - Get Free Report) are bot
WOBURN, Mass., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or t
WOBURN, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or t
WOBURN, Mass., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or t
Biofrontera Inc. (NASDAQ: BFRI - Get Free Report)'s stock price traded down 5.6% during mid-day trad
On Friday, 137 stocks made new 52-week lows.
During Monday's trading, 1214 companies set new 52-week lows.